New innovative technology platform has creating the next generation of DNA or RNA vaccines based on the genetic code of the pathogenic agents. Drug delivery systems are come up with technologies for the targeted delivery and/or controlled release of therapeutic agents. Drugs have long been used to upgrade health condition and increase lives. Technological advances in immunology, protein design, and genetic delivery have unlocked new possibilities for vaccine concepts and delivery technology that were previously inaccessible. The most important requirements are a vaccine should be safe and efficacious can be restated as a formulation that it is made with the appropriate potency that persists over the duration of conditions until it is administered to the patient.
Title : Novel regulatory mechanisms of innate immunity and inflammation
Ping Xie, Rutgers University, United States
Title : Human challenge clinical trial of vaccines for infectious diseases – A necessary evil
Sudhakar Bangera, AILEEN Clinical Research Services, India
Title : Your vaccine attitude determines your altitude. What are the determinants of attitudes toward vaccination
Vincenzo Alfano, University of Napoli Parthenope, Italy
Title : Neutralizing antibodies response to SARS-COV-2 XBB1.5 mRNA vaccine in nephrology patients on dialysis against different viral variants
Agostino Riva, University of Milan, Italy
Title : Why Antimicrobial Resistance is a Global Threat and Its Impact On Everyone
Regina Au, BioMarketing Insight, United States
Title : The influence of physical factors on recombinant human serum albumin
Patrycja Dolibog, Medical University of Silesia in Katowice, Poland
Title : Current investments and future directions of biomedical advanced research and development authority’s CBRN vaccines portfolio
Lindsay Parish, BARDA, United States
Title : Development and characterization of a virus-like particle-based subunit vaccine candidate against Indian isolate of Porcine Circovirus 2d
Rajib Deb, ICAR-National Research Centre on Pig, India
Title : The Ethiopian vaccine supply chain and logistics system’s performance after the last mile delivery initiative: Phenomenological study
Samson Gebremedhin Gebreselassie, Project HOPE, Ethiopia
Title : Limits of vaccine quality control in India: Possible solutions
Bhoj R Singh, Indian Veterinary Research Institute, India